top of page

Peer Reviwed Publications (Best 5)

Rej, A., A. Paladhi, S. Daripa, D. Sarkar, S. Bhattacharyya, I. Mondal and S. K. Hira (2023). Galunisertib synergistically potentiates the doxorubicin-mediated antitumor effect and kickstarts the immune system against aggressive lymphoma. International Immunopharmacology, 114: 109521. https://doi.org/10.1016/j.intimp.2022.109521
Hira, S. K., A. Rej, A. Paladhi, R. Singh, J. Saha, I. Mondal, S. Bhattacharyya and P. P. Manna (2020). Galunisertib Drives Treg Fragility and Promotes Dendritic Cell-Mediated Immunity against Experimental Lymphoma. iScience 23(10).https://doi.org/10.1016/j.isci.2020.101623   
Full List Peer Reviwed Publications
US-NLM-PubMed-Logo.svg.webp
Google Scholar Citations

1,594

Citations

24

h-index

51

i10-index

Collaborate With Us

For research collaborations, material requests, or scientific enquiries, please write to us.

bottom of page